Camcevi União Europeia - polonês - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - nowotwory stercza - terapia endokrynologiczna - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Vabysmo União Europeia - polonês - EMA (European Medicines Agency)

vabysmo

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - okulistyka - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Klisyri União Europeia - polonês - EMA (European Medicines Agency)

klisyri

almirall, s.a. - tirbanibulin - keratosis, actinic - antybiotyki i chemioterapeutyki do użytku dermatologicznego - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.